Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Surufatinib”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Testing effectiveness (Phase 2)Looking for participantsNCT06876844
What this trial is testing

Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck CancerHead and Neck Cancer Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 24
Not applicableNot Yet RecruitingNCT06156332
What this trial is testing

Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy

Who this might be right for
Advanced Solid Tumors With Neuroendocrine Differentiation
Shanghai Changzheng Hospital 39
Testing effectiveness (Phase 2)Study completedNCT05077384
What this trial is testing

Open-label Study of Surufatinib in Japanese Patients

Who this might be right for
Neuroendocrine TumorsNon-hematologic Malignancy
Hutchmed 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05988372
What this trial is testing

Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)

Who this might be right for
Locally Advanced Pancreatic Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06719700
What this trial is testing

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Who this might be right for
ToripalimabSurufatinibChemoradiotherapy+1 more
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Looking for participantsNCT06708858
What this trial is testing

Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Dai, Guanghai 35
Large-scale testing (Phase 3)Looking for participantsNCT07505472
What this trial is testing

Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria

Who this might be right for
Rectal Cancer
The First Hospital of Jilin University 212
Very early researchStudy completedNCT03627520
What this trial is testing

A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion of [14C]Sulfatinib

Who this might be right for
Healthy
Hutchison Medipharma Limited 6
Testing effectiveness (Phase 2)UnknownNCT04922658
What this trial is testing

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06437353
What this trial is testing

Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer

Who this might be right for
Ovarian Cancer
Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Early research (Phase 1)Study completedNCT04755088
What this trial is testing

Surufatinib Renal Impairment Study

Who this might be right for
Renal Impairment
Hutchison Medipharma Limited 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375642
What this trial is testing

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT06378580
What this trial is testing

The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Luo Cong 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07279532
What this trial is testing

Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System

Who this might be right for
Neuroendocrine Neoplasms (Tumours)
Second Affiliated Hospital, School of Medicine, Zhejiang University 35
Not applicableUnknownNCT05056116
What this trial is testing

A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
The Affiliated Hospital of Xuzhou Medical University 30
Testing effectiveness (Phase 2)Study completedNCT02614495
What this trial is testing

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
Hutchison Medipharma Limited 66
Testing effectiveness (Phase 2)Looking for participantsNCT05218889
What this trial is testing

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerPDAC - Pancreatic Ductal AdenocarcinomaPancreas Cancer+1 more
Chinese PLA General Hospital 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05908747
What this trial is testing

Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 29
Early research (Phase 1)Ended earlyNCT04427774
What this trial is testing

Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

Who this might be right for
Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 8
Load More Results